AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Liquid–liquid phase separation-related patterns in glioblastoma: Immune landscape, prognostic features, and therapeutic resistance

Shengqi Hua,b,1Jiajia Gaob,c,1Jing Wange,1Fusheng Liub,c( )Chun Zengb,d( )
Department of Interventional Neuroradiology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
Department of Neurosurgery, Beijing TianTan Hospital, Capital Medical University, Beijing 100070, China
Brain Tumor Research Center, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
China National Clinical Research Center for Neurological Diseases, Beijing 100070, China
Department of Neurosurgery, Peking University International Hospital, Beijing 100070, China

1 These authors contributed equally to this work.

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Hu S, Gao J, Wang J, et al. Liquid–liquid phase separation-related patterns in glioblastoma: Immune landscape, prognostic features, and therapeutic resistance. Genes & Diseases, 2026, 13(1). https://doi.org/10.1016/j.gendis.2025.101562

211

Views

2

Downloads

1

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 27 August 2024
Published: 18 February 2025
© 2025 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).